Sellas Life Sciences Group Inc (SLS)

Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Cost Of Revenue	-	-	-	-	-
Costs And Expenses	14.88%10.63	9.25	8.26	7.08	6.87
Operating Income/Loss	14.88%-10.63	-9.25	-8.26	-7.08	-6.87
Nonoperating Income/Loss	21.18%1.02	0.85	0.60	0.29	0.27
	14.25%-9.61	-8.41	-7.66	-6.79	-6.60
Attributable To Parent	14.25%-9.61	-8.41	-7.66	-6.79	-6.60
Basic Average Shares	9.68%189.18	172.48	-	108.40	98.56
Diluted Average Shares	9.68%189.18	172.48	-	108.40	98.56
Basic Earnings Per Share	-0.05	-0.05	-	-0.06	-0.07
Diluted Earnings Per Share	-0.05	-0.05	-	-0.06	-0.07